Opinion

... in response to New head louse treatment shows promise
  1. "NitWashing"
    Pediculosis Assoc Pediculosis Assoc United States says:
    March 29, 2013 at 11:33 AM

    FDA warns Parapro on claims for Natroba including the way their video news release "entirely omits all risk information, including the warning and precaution regarding benzyl alcohol toxicity and the most frequently reported adverse events from the PI. By omitting the most serious and frequently occurring risks associated with the drug, the VNR misleadingly suggests that Natroba is safer than has been demonstrated."

    www.fda.gov/.../UCM341633.pdf

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback